2018 annual financial data

TransCode Therapeutics, Inc. 2018 Operating margin

TransCode Therapeutics, Inc. 2018 operating margin with verified reported value…

Direct answer

Operating margin was Not calculable.

Operating income was -383,996 USD and net income was -453,440 USD.
Operating cash flow was -299,572 USD.

Get free TransCode Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
Not available
Operating income
-383,996 USD
Net income
-453,440 USD
Operating cash flow
-299,572 USD